Related Experiment Videos
Fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in the murine genome
M Djalali1, S Adolph, P Steinbach
1Abteilung Klinische Genetik der Universität, Ulm, FRG.
Abstract:
The cytosine analogues 5-azacytidine and 5-azadeoxycytidine were used to induce fragile sites on mouse chromosomes. Sites of relative frequent fragility were ascertained and compared with fragile sites induced by the antimetabolites methotrexate, fluorodeoxyuridine and aphidicolin as reported previously. Considerable overlap of fragile sites induced by the very different agents is evident. Fragile sites are common to all chromosomes and most of them are susceptible to different modes of induction.
Insights
Cytosine analogues like 5-azacytidine induce fragile sites on mouse chromosomes. These fragile sites show significant overlap with those induced by other agents, indicating common susceptibility across chromosome types.
Area of Science:
- Cytogenetics
- Molecular Biology
- Genetics
Background:
- Fragile sites are specific chromosomal regions prone to breakage.
- Various agents, including antimetabolites, are known to induce fragile sites.
- Understanding the mechanisms and commonalities of fragile site induction is crucial for genetic research.
Purpose of the Study:
- To investigate the ability of cytosine analogues (5-azacytidine and 5-azadeoxycytidine) to induce fragile sites in mouse chromosomes.
- To compare the induced fragile sites with those previously reported for other antimetabolites (methotrexate, fluorodeoxyuridine, aphidicolin).
- To identify commonalities and differences in fragile site induction by diverse agents.
Main Methods:
- Treatment of mouse chromosomes with 5-azacytidine and 5-azadeoxycytidine.
- Identification and mapping of induced fragile sites.
- Comparative analysis of fragile site locations with previously published data.
Main Results:
- Cytosine analogues successfully induced fragile sites on mouse chromosomes.
- A considerable overlap was observed between fragile sites induced by cytosine analogues and those induced by methotrexate, fluorodeoxyuridine, and aphidicolin.
- Fragile sites were found on all chromosomes and appeared susceptible to multiple induction methods.
Conclusions:
- The study demonstrates that cytosine analogues are effective in inducing chromosomal fragile sites.
- The overlap in fragile sites suggests common underlying mechanisms or susceptibility across different inducing agents.
- Fragile sites represent a conserved feature of chromosomes, responsive to various genotoxic stresses.